Stock Track | Harrow Health Plunges 10.43% After-Hours on Earnings Miss and Weak Guidance

Stock Track
Mar 03

Harrow Health Inc. (HROW) experienced a significant after-hours plunge of 10.43% following the release of its fourth-quarter and full-year 2025 financial results.

The sharp decline came as the company reported quarterly earnings that fell significantly short of analyst expectations. Harrow posted Q4 earnings per share of $0.17, which not only represented a decrease from $0.24 in the same period a year earlier but also missed the FactSet consensus estimate of $0.37 by a wide margin.

Adding to investor concerns, the company issued 2026 revenue guidance of $350 million to $365 million, which falls substantially below analyst expectations of $391.4 million. This combination of an earnings miss and weaker-than-expected forward outlook prompted the after-hours selloff.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10